Severe Thrombocytopenia in a Patient with Submassive Pulmonary Embolism and Heparin-Induced Thrombocytopenia: to Lyse or Not to Lyse?-Reference-Cited by-同舟云学术

Severe Thrombocytopenia in a Patient with Submassive Pulmonary Embolism and Heparin-Induced Thrombocytopenia: to Lyse or Not to Lyse?

Published:2020-10-19 Issue:12 Volume:2 Page:2749-2753
ISSN:2523-8973
Container-title:SN Comprehensive Clinical Medicine
language:en
Short-container-title:SN Compr. Clin. Med.

Author:

Sheth Chirag,Asava-Aree Chompunut,Randhawa Mandeep Singh,Bartholomew John R.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42399-020-00580-x.pdf

Reference23 articles.

1. Baroletti SA, Goldhaber SZ. Heparin-induced thrombocytopenia. Circulation. 2006;114(8):e355–6. https://doi.org/10.1161/CIRCULATIONAHA.106.632653.

2. Kiser TH, Burch JC, Klem PM, Hassell KL. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2008;28(9):1115–24. https://doi.org/10.1592/phco.28.9.1115.

3. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 2001;103(14):1838–43. http://www.ncbi.nlm.nih.gov/pubmed/11294800 .

4. Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med. 163(15):1849–56. https://doi.org/10.1001/archinte.163.15.1849.

5. Mahaffey KW, Lewis BE, Wildermann NM, Berkowitz SD, Oliverio RM, Turco MA, et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol. 2003;15(11):611–6. http://www.ncbi.nlm.nih.gov/pubmed/14608128 .

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enoxaparin sodium/heparin;Reactions Weekly;2020-11